Nathaniel Calloway - 08 Jul 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Director
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for Nathaniel Calloway
Issuer symbol
LFCR
Transactions as of
08 Jul 2024
Net transactions value
$0
Form type
4
Filing time
10 Jul 2024, 19:52:03 UTC
Previous filing
17 Jun 2024
Next filing
07 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +30,000 +107% 58,069 08 Jul 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration.